Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Drug Release Characteristics01:22

Modified-Release Drug Delivery Systems: Drug Release Characteristics

Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supramolecular PDDA/PEDOT:PSS Biosensor for Early Pancreatic Cancer Detection via CA19-9: Clinical Validation on Human Blood Samples.

ACS omega·2026
Same author

Ultrathin nanocapacitor assembled via atomic layer deposition.

Nanotechnology·2024
Same author

Optimizing herbicide selection for pre-emergence control of itchgrass and cypressvine morningglory in sugarcane.

Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes·2024
Same author

Virus adsorbent systems based on Amazon holocellulose and nanomaterials.

Microscopy research and technique·2024
Same author

Nanoarchitectonic E-Tongue of Electrospun Zein/Curcumin Carbon Dots for Detecting <i>Staphylococcus aureus</i>in Milk.

ACS omega·2023
Same author

PLGA-PVA-PEG Single Emulsion Method as a Candidate for Aminolevulinic Acid (5-ALA) Encapsulation: Laboratory Scaling Up and Stability Evaluation.

Molecules (Basel, Switzerland)·2022

Related Experiment Video

Updated: May 8, 2026

Prescribed 3-D Direct Writing of Suspended Micron/Sub-micron Scale Fiber Structures via a Robotic Dispensing System
10:36

Prescribed 3-D Direct Writing of Suspended Micron/Sub-micron Scale Fiber Structures via a Robotic Dispensing System

Published on: June 12, 2015

8.4K

Machine learning-enhanced nanofiber systems: A new frontier in controlled drug release.

Gabriella Onila Nascimento Soares1, Vitor Santi2, Andrey Coatrini Soares3

  • 1Materials Engeneering Departament, University of Sao Paulo, Avenida joão Dagnone, 1100 - Santa Angelina, São Carlos, São Paulo, 13563120, BRAZIL.

Nanotechnology
|January 15, 2026
PubMed
Summary

Machine learning (ML) accelerates the development of nanofiber-based drug delivery systems (N-DDS). ML models predict and optimize material properties, fabrication, and drug release, advancing precision medicine.

Keywords:
Nanofibersartificial intelligencedrug delivery systemsmachine learningpolymers

More Related Videos

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.2K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.5K

Related Experiment Videos

Last Updated: May 8, 2026

Prescribed 3-D Direct Writing of Suspended Micron/Sub-micron Scale Fiber Structures via a Robotic Dispensing System
10:36

Prescribed 3-D Direct Writing of Suspended Micron/Sub-micron Scale Fiber Structures via a Robotic Dispensing System

Published on: June 12, 2015

8.4K
Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.2K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.5K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Pharmacology

Background:

  • Nanofiber-based drug delivery systems (N-DDS) offer significant advantages for controlled release due to their high surface area and tunable properties.
  • Optimizing N-DDS involves numerous interdependent parameters, making traditional development methods time-consuming and inefficient.
  • Electrospinning is a key fabrication technique for creating these advanced drug delivery platforms.

Purpose of the Study:

  • To review the application of machine learning (ML) in accelerating the design and optimization of N-DDS.
  • To highlight how ML replaces trial-and-error with predictive modeling for N-DDS development.
  • To discuss the potential of ML-integrated N-DDS for future therapeutic applications.

Main Methods:

  • Bibliometric analysis of literature on nanofibers and drug delivery systems (DDS), focusing on electrospinning.
  • Review of ML applications in polymer selection, electrospinning process optimization, and encapsulation strategies.
  • Analysis of ML model performance in predicting nanofiber morphology, encapsulation efficiency, and drug release kinetics.

Main Results:

  • ML models demonstrate high predictive accuracy in tailoring N-DDS characteristics.
  • Case studies show ML effectively optimizes parameters for desired drug release profiles.
  • The review identifies key challenges for clinical translation, including data quality and scalability.

Conclusions:

  • ML integration is crucial for advancing N-DDS development beyond traditional methods.
  • ML-driven N-DDS hold promise for patient-specific, sustainable, and scalable therapeutic solutions.
  • The synergy of ML and nanofiber engineering paves the way for precision medicine.